Biotechnology

Polar Capital Healthcare Opportunities breaches 10% exposure limit after Danish pharma firm soars

Funds

Polar Capital Healthcare Opportunities breaches 10% exposure limit after Danish pharma firm soars

Zealand Pharma A/S

clock 02 April 2024 • 1 min read
Candriam overhauls thematic global equity team in succession planning push

People moves

Candriam overhauls thematic global equity team in succession planning push

Rudi Van den Eynde to retire in 2025

clock 13 February 2024 • 2 min read
Wise Funds: Biotech bargains offer buying opportunity amid volatile markets

Investment Trusts

Wise Funds: Biotech bargains offer buying opportunity amid volatile markets

Ageing population underpinning demand

clock 27 April 2022 • 4 min read
BB Healthcare's Paul Major: Biotech trust sector marred by 'dubious' company influx

Investment Trusts

BB Healthcare's Paul Major: Biotech trust sector marred by 'dubious' company influx

Recent roundtable

clock 06 April 2022 • 3 min read
You don't need to guess the winners in biotech

Industry

You don't need to guess the winners in biotech

Sector prone to volatility

clock 23 February 2022 • 5 min read
Biotech sell-off continues as investors turn to safer assets amid rising inflation - reports

Equities

Biotech sell-off continues as investors turn to safer assets amid rising inflation - reports

Out of favour

clock 10 February 2022 • 2 min read
BB Biotech's Dallas Webb: 'The fundamentals of biotech have never been stronger'

Equities

BB Biotech's Dallas Webb: 'The fundamentals of biotech have never been stronger'

Biotechnology Q&A

clock 24 January 2022 • 4 min read
Biotech and healthcare investors hope for rebound following weak 2021

Equities

Biotech and healthcare investors hope for rebound following weak 2021

Targeting long-term structural changes

clock 21 January 2022 • 5 min read
Conditional drug approvals set to expand biotech universe

Technology

Conditional drug approvals set to expand biotech universe

Weighing up risk vs reward

clock 20 December 2021 • 4 min read

Technology

Alzheimer's breakthrough signals game changer for biotech sector

The accelerated approval of the first new Alzheimer's treatment in almost two decades looks set to drive a new wave of biotech innovation and investment.

clock 30 June 2021 • 4 min read
Trustpilot